Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bio-One acquisition

This article was originally published in The Tan Sheet

Executive Summary

Orlando, Fla.-based supplement firm purchases fifth majority stake in a Chinese herbal company in recent months with acquisition of 51% share of a firm in the Henan Province; the acquisition is expected to close in 90 days. The Chinese firm, which reported $17 mil. in 2003 revenues, will retain its present management team. The deal continues Bio-One's vertical integration and international expansion strategy following the April purchase of Canadian distributor and manufacturer INI (1"The Tan Sheet" April 12, 2004, p. 12)...

You may also be interested in...

Bio-One Supplement Firm Buys Interactive Nutrition International

Bio-One continues its aggressive acquisition strategy with its purchase of Canadian manufacturer and distributor Interactive Nutrition International, the firm announced April 1

Finland's Forendo Attracts Big Pharma For Liver Disease R&D

Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.


Decision Time For MSD/AZ, Lilly, Kite EU Fast-Track Hopes

Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts